1. Introduction {#sec0005}
===============

*Leishmania infantum (Li)*,[1](#fn0005){ref-type="fn"} is a vector-borne zoonotic disease transmitted by phlebotomine sand flies and dogs are considered the main reservoir host of the parasite ([@bib0470]). In fact, the majority of infected dogs do not show clinical signs or develop a mild disease and sustain the survival of the parasite during cold seasons when vectors are not active ([@bib0040]; [@bib0355]). A huge amount of investigations have been − and still are − performed to better understand pathomechanisms of canine leishmaniosis (CanL)[2](#fn0010){ref-type="fn"} make early and accurate diagnosis, manage the disease and prevent spreading of the infection.

Feline leishmaniosis (FeL)[3](#fn0015){ref-type="fn"} caused by *Li* appears as an emerging feline disease, in fact in the past two decades it was more and more frequently reported in endemic areas and sporadically seen also in non-endemic areas in rehomed cats ([@bib0405]; [@bib0410]; [@bib0340]; [@bib0230]; [@bib0035]; [@bib0375]). However, the increased level of medical care given to cats contributed to the «emergence» of FeL as well as availability of more sensitive diagnostic tools and progress in understanding parasite-host-vector interactions ([@bib0080]).

In recent years, more detailed information on FeL has been published and it increased evidence that there are more similarities with CanL than it was speculated in the past and the aim of this review is to summarize current knowledge about FeL focusing on similarities and differences with CanL.

2. Etiology, diffusion and transmission {#sec0010}
=======================================

Cats were found infected by the same *Leishmania* spp. detected in dogs and *L. infantum* is the species most frequently reported in both dogs and cats in the Old World and in Central and South America. *Leishmania infantum* has been detected in cats in Mediterranean countries (Italy, Spain, Portugal, France, Greece, Turkey, Cyprus), Iran and Brazil ([@bib0340]; [@bib0075]; [@bib0015]; [@bib0260]). Zymodeme MON1 is the most frequently characterized zymodeme in dogs, cats and humans in the Mediterranean area ([@bib0230]; [@bib0340]; [@bib0390]). However, *L. infantum* antibody and molecular prevalence is usually considered lower in cats compared to dogs as well as cases of FeL are more rare ([@bib0300]; [@bib0340]). Sporadic or rare occurrence of both CanL and FeL in non-endemic areas can be the consequence of rehoming or travelling of companion animals ([@bib0470]; [@bib0355]; [@bib0105]; [@bib0500]; [@bib0410]; [@bib0405]; [@bib0050]). Other *Leishmania* species are found in both dogs and cats in the New World (*Leishmania amazonensis, Leishmania braziliensis, Leishmania mexicana, Leishmania venezuelensis*) ([@bib0470]; [@bib0340]). *Leishmania tropica* and *Leishmania major* were rarely reported in dogs and found mainly associated with skin or mucocutaneous lesions ([@bib0025]). Recently, these latter species were confirmed in cats in Turkey ([@bib0075]; [@bib0310]).

Sand fly-transmission is considered the most important way of transmission of *Leishmania* to humans and animals and, according to several studies about the feeding habit of sand flies, this is likely also in feline infection but it has never been investigated ([@bib0175]; [@bib0340]).

Non-vectorial transmission ways of CanL are now well known and responsible for autochtonous cases in non-endemic areas ([@bib0470]; [@bib0195]; [@bib0285]; [@bib0500]) but similar information about FeL is lacking. However, blood transfusion could be a source of infection in cats as it is proven in dogs and humans. In endemic areas healthy cats − similarly to healthy dogs and humans − can be found positive at blood PCR ([@bib0345]; [@bib0075]; [@bib0365]; [@bib0015]; [@bib0010]; [@bib0065]; [@bib0145]; [@bib0260]; [@bib0300]).

3. Pathogenesis and clinical features {#sec0015}
=====================================

It is currently known that susceptibility to progressive infection and development of lesions and clinical signs in dogs is mostly linked to adaptive immune response evolving to immune exhaustion and associated with a predominant T helper 2 (Th2) and an impaired T helper 1 (Th1) response ([@bib0470]; [@bib0155]). A similar pattern of humoral and cell mediated adaptive immune response is elicited by *L. infantum* in cats from endemic areas ([@bib0395]). In fact, it was recently observed in a study involving cats from Italy and Spain that about one fourth of them produce *L. infantum* specific IFNγ by *ex vivo* stimulated blood and they have a significantly lower antibody level compared to non-producer cats ([@bib0395]). Sick dogs with severe clinical disease, high blood parasitemia and antibody level, lack in specific IFN-γ production by *ex vivo* stimulated whole blood ([@bib0485]). Cats with *L. infantum*-associated clinical disease have high blood parasitemia and low to very high antibody levels but relationship between antibody titer and severity of disease and also their specific IFN-γ production were not investigated ([@bib0030]; [@bib0035]; [@bib0060]; [@bib0140]; [@bib0230]; [@bib0340], [@bib0350]; [@bib0375]). However, longitudinal studies confirmed that progression to disease is associated in cats with increasing antibody titers as it occurs in CanL ([@bib0170]; [@bib0240]). Moreover, in followed up cases of FeL clinical improvement obtained by anti- *L. infantum* therapy is associated with significant reduction of antibody level as it is reported in canine mild or moderate disease cases ([@bib0325]; [@bib0480]).

Duration of incubation is extremely variable in CanL but diagnoses obtained in animals imported to non-endemic areas years before demonstrate that it can be very long lasting in both dogs and cats ([@bib0410]; [@bib0405]; [@bib0475]).

A complex genetic background modulates susceptibility or resistance of dogs and it contributes to the wide and dynamic clinical spectrum of CanL including subclinical infection, self-limiting mild disease or severe progressive illness ([@bib0125]; [@bib0470]). In the Balearic Islands the immunological pattern of resistant dogs is more frequently found in the autochthonous Ibizan Hounds than in other breeds and these dogs rarely develop clinical leishmaniosis ([@bib0250]; [@bib0460]). [@bib0420] studied polymorphism and mutations of the solute carrier family 11, member 1 gene (Slc11a1), also known as natural resistance-associated macrophage protein 1 gene (Nramp1), and they found a breed-specific haplotype distribution (six haplotypes exclusively found in Ibizan Hounds) and one haplotype significantly associated with the disease ([@bib0425], [@bib0420]). Moreover, in Boxer dogs from endemic area specific alleles were respectively associated with susceptibility to severe disease or were found in healthy old individuals supposed to be resistant to clinical leishmaniosis, and analysis of single nucleotide polymorphisms confirmed as well the genetic component of the disease in this breed ([@bib0400]; [@bib0420]). Genetic susceptibility may explain a peak of higher disease prevalence reported in dogs younger than three years ([@bib0005]). Conversely, immunosenescence and the progressive chronic course of disease may explain another peak of disease seen in dogs older that eight years ([@bib0005]; [@bib0130]). Age range of cats reported with FeL is wide (2--21 years), however they are mostly mature cats (7--10 years old) at diagnosis and very few have 2--3 years of age ([@bib0030]; [@bib0035]; [@bib0070]; [@bib0185]; [@bib0290]; [@bib0340], [@bib0350]). Moreover, FeL was never reported in pedegree cats so that at present there are no data supporting a genetic susceptibility to the disease in some cats. However, studies comparing the genetic background of infected cats according to their clinical status can elucidate mechanisms of susceptibility of feline hosts going beyond the somatic phenotype of domestic shorthair cats (*Felis silvestris domesticus*) that have undergone thousands of years of natural selection in endemic areas. As concerning the age of cats affected by FeL, this is a further datum to support a chronic course of the disease as in dogs.

Other vector-borne co-infections (e.g. *Dirofilaria immitis*, *Ehrlichia canis*, *Hepatozoon canis*) can influence parasite burden and progression of CanL ([@bib0135]; [@bib0280]; [@bib0505]). In cats the association between retroviral, coronavirus, *Toxoplasma* or some vector-borne co-infections in cats antibody and/or PCR positive to *L. infantum* has been explored ([@bib0015]; [@bib0020]; [@bib0330], [@bib0320], [@bib0315]; [@bib0365]; [@bib0440]; [@bib0450]; [@bib0465]; [@bib0495], [@bib0490]; [@bib0520]). A significant association between Feline Immunodeficiency Virus (FIV) and *L. infantum* positivity was found only in few cases ([@bib0315]; [@bib0450]; [@bib0490]). However, the review of 89 reported cases of FeL where cats were serologically tested for FIV and Feline Leukemia Virus (FeLV) provides a 30.3% prevalence of FIV coinfection in cats with FeL and only four cats with FeLV co-infection (three of them also FIV positive) were detected ([@bib0030]; [@bib0035]; [@bib0060]; [@bib0070]; [@bib0085]; [@bib0110]; [@bib0115]; [@bib0140]; [@bib0165]; [@bib0180]; [@bib0185]; [@bib0190]; [@bib0205]; [@bib0210]; [@bib0235]; [@bib0265]; [@bib0305]; [@bib0335]; [@bib0375]; [@bib0380]; [@bib0385]; [@bib0410]; [@bib0405]; [@bib0415]; [@bib0510]; [@bib0515]). Other FeL cases reported in FIV negative cats were diagnosed in animals affected by immune-mediated diseases (and treated with immunosuppressive drugs), neoplasia, or diabetes mellitus ([@bib0030]; [@bib0035]; [@bib0085]; [@bib0205]; [@bib0210]; [@bib0230]; [@bib0235]; [@bib0240]; [@bib0265]; [@bib0405]) and impaired immuno-competence is overall suspected in about half clinical cases of FeL. In the face of a great number of both experimentally and field controlled prospective studies on CanL, no prospective controlled study is available on immune mechanisms involved in the pathogenesis of FeL. A time-limited (post infection follow up duration of 8--24 weeks) experimental study with strains of *L. infantum* was performed in few cats back in 1984 ([@bib0200]). Methodologies used in that study let us conclude only that infection was established and cats produced specific antibodies ([@bib0200]). A more recent experimental study was performed by intradermal inoculation of stray cats (some found co-infected by FeLV) with *Leishmania braziliensis* ([@bib0445]). In this latter study, dissemination of the parasite from the primary site of infection and development of multifocal skin nodules were described. Interestingly, ulceration of nodules followed by spontaneous healing recurred several times and seroconversion was detected when the size of skin lesions decreased. Self-cure of skin lesions was documented as well as the persistence of antibodies in both clinically cured cats and in the only one with a subsequent recurrence ([@bib0445]).

Currently, in areas endemic for *L. infantum,* FeL is less frequently reported than CanL. Case reports published in recent years provided information on the most common clinical signs and clinico-pathological abnormalities associated with FeL ([@bib0030]; [@bib0035]; [@bib0055]; [@bib0140]; [@bib0230]; [@bib0340], [@bib0350]; [@bib0375]). However, coinfections or comorbidities are frequently detected in these cats and they can contribute to a misrepresentation of clinical FeL albeit lesions associated with the presence of the parasite have been detected in skin, lymph nodes, spleen, bone marrow, liver, oral mucosa, stomach, large bowel, kidney, nasal exudate, lung, eye ([@bib0355]). Less frequent and less severe clinical presentations could currently be unreported and we are presumably underestimating the clinical relevance of FeL. As it is reported in CanL, skin or mucocutaneous lesions are the most common reason for veterinary consultation and finding on physical examination in cats with leishmaniosis ([@bib0030]; [@bib0035]; [@bib0060]; [@bib0140]; [@bib0230]; [@bib0340], [@bib0350]; [@bib0430]). Moreover, diverse macroscopic skin lesions can occur in the same dogs or cats. Similarly, ocular manifestations are frequently found in dogs and cats affected by leishmaniosis and can be the reason for consultations ([@bib0030]; [@bib0150]; [@bib0355]; [@bib0350]; [@bib0375]). Clinical findings detected in CanL and FeL and their frequency are compared in [Table 1](#tbl0005){ref-type="table"} .Table 1Frequency of clinical signs, lesions and clinicopathological abnormalities detected in dogs and cats with leishmaniosis ([@bib0150]; [@bib0340]; [@bib0430]; [@bib0470]).Table 1Comparison of clinical and clinicopathological abnormalities reported in CanL and FeLClinical signs and lesionsDOGSCATS**GENERAL++++++** Lymphadenomegaly++++++ Weight loss++++ Anorexia+++ Polyphagia+NR Lethargy++ Pale mucous membranes+++ Fever++ Polyuria and polydypsia++**CUTANEOUS++++++** Exfoliative dermatitis (alopecia +/−)++/++++ Ulcerative dermatitis+/++++ Nodular dermatitis++ Papular dermatitis+NR Sterile pustular dermatitis+NR Onychogriphosis+/+++NR Nasal/footpad hyperkeratosis++NR Hemorrhagic blister/bullaNR+**OCULAR+/+++++** Blepharitis++ Conjunctivitis++ Keratoconjunctivitis+++ Uveitis+++**OTHER++**++ Mucocutaneous/mucosal lesions++ Vomiting/diarrhoea++ Stomatitis+++ Splenomegaly++ Vascular disorders+NR Epistaxis+NR Chronic nasal dischargeNR+ Lameness+NR Atrophic masticatory myositis+NR Neurologic disease+NR** Abortion**NR+**Laboratory abnormalities**NR/++++++ Hyperglobulinemia++/++++++ Hypoalbuminemia++ Mild to moderate non regenerative anemia++++ Leukocytosis/Leukopenia++ Thrombocytopenia++ PancytopeniaNR+ Impaired secondary hemostasis and fibrinolysis+NR Proteinuria++ Renal azotemia++ Elevated liver ezyme activities+NR[^1]

4. Diagnosis {#sec0020}
============

*Leishmania* amastigotes are found in infected feline macrophages in lymph nodes, bone marrow, skin, mucosal or eye lesions and rarely in circulating neutrophils as it occurs in dogs ([@bib0030]; Basso et al., 2016, p. 20; [@bib0060]; [@bib0165]; [@bib0230]; [@bib0340], [@bib0350]; [@bib0375]). Cytological investigations from the above tissues provide useful information about the pathogenesis of suspected lesions, can confirm diagnosis and require minimally invasive procedures in both dogs and cats. As in dogs, lymphoid hyperplasia is the most common lymph node cytological pattern seen in *L. infantum* PCR positive feline lymph nodes, and it was found irrespective to the clinical status of cats, their antibody titer or FIV co-infection ([@bib0360]; [@bib0455]).

Histological evaluation of dog and cat lesions is also used and granulomatous inflammation is usually found associated with FeL as described in dogs ([@bib0140]; [@bib0165]; [@bib0230]; [@bib0265]; [@bib0290]). It was particularly useful to detect associated feline skin diseases such as squamous cell carcinoma, pemphigus foliaceus, and eosinophilic granuloma found in some cats with FeL ([@bib0180]; [@bib0205]; [@bib0230]; [@bib0275]; [@bib0380]; [@bib0405]). Immunohistochemistry evidences the parasites in feline tissues and heterologous (canine or rabbit) hyperimmune serum or monoclonal antibody were used as primary antibody ([@bib0265]; [@bib0290]).

Molecular investigations of *Leishmania* DNA are largely used with the same methodologies for both CanL and FeL diagnosis ([@bib0340]; [@bib0470]). In feline epidemiological investigations most studies were performed on EDTA-blood and usually a lower positivity rate was found in cats compared to dogs from the same area ([@bib0300]; [@bib0340]). Limited data are available about other tissues (lymph node, bone marrow, skin) or non-invasive sampling (conjunctival or oral swabs) ([@bib0045]; [@bib0065]; [@bib0300]; [@bib0340]). Biopsied skin or mucosal lesions and bone marrow or lymph node samplings obtained from sick cats have usually high parasite loads measured by quantitative real time PCR ([@bib0265]) as seen in dogs.

Culture of infected tissues was rarely performed because it is restricted to research laboratories and time consuming but it provided feline strains that in most cases showed the same zymodemes and genotypes detected in dogs or humans ([@bib0230]; [@bib0340]; [@bib0390]).

Anti- *Leishmania* antibody detection has been extensively used in cats for research and clinical aims by means of IFAT, ELISA, DAT and Western blot (WB) techniques ([@bib0340]). Cut off setting for IFAT was established at 1:80 dilution that is similar to that used in dogs and almost all cats affected by clinical FeL have low to very high antibody level ([@bib0030]; [@bib0035]; [@bib0060]; [@bib0140]; [@bib0230]; [@bib0350], [@bib0340], [@bib0330]; [@bib0375]). However, FeL cannot be excluded only on the basis of a negative serological test because, as in dogs, discrepancies are known between IFAT, ELISA, DAT and WB ([@bib0170]; [@bib0370]; [@bib0470]). Recently diagnostic performance of ELISA, IFAT and WB were compared in cats and WB offered best sensitivity and specificity ([@bib0370]).

When serological and molecular tests are used at the same time discrepancies can be seen in cats as it occurs in dogs ([@bib0170]; [@bib0340]; [@bib0470]). The lack of consistency among serology and molecular tests can depend on their different performances (sensitivity and specificity) obviously influenced by many different factors.

5. Treatment and prognosis {#sec0025}
==========================

Treatment of cats with clinical FeL is still empirically based and off label by using the most common drugs prescribed to dogs and a clinical cure is usually obtained as in dogs ([@bib0030]; [@bib0035]; [@bib0060]; [@bib0140]; [@bib0230]; [@bib0340], [@bib0350]; [@bib0375]; [@bib0475]). This means that efficacy and safety of used protocols have never been evaluated in controlled studies and cats should be monitored very carefully for adverse effects during treatment (particularly cats affected by renal disease) and for possible clinical recurrence after stopping therapy ([@bib0340], [@bib0350]). Long-term oral administration of allopurinol as monotherapy or maintenance treatment after a course of subcutaneous injections of meglumine antimoniate are the most frequently used regimens. However, two cats stopped allopurinol monotherapy because of acute kidney injury after few weeks of therapy ([@bib0350]). Domperidone was recently used in two cats in association with allopurinol and miltefosine was given in one other case ([@bib0030]; [@bib0140]; [@bib0230]). It should however be considered that propylene glycol is among the excipients of the miltefosine oral formulation licensed for the treatment of CanL (Milteforan™) and that it causes Heinz body formation and decreased life span in feline red blood cells but this latter adverse effect was not evaluated in the reported case ([@bib0100]; [@bib0230]).

Life expectancy of cats with clinical FeL is usually good (several years after diagnosis) unless concurrent conditions or complications occur ([@bib0340], [@bib0350]). However, according to a retrospective evaluation of 14 cases, prognosis is not significantly influenced by therapy or retroviral coinfection ([@bib0350]).

6. Prevention of *L. infantum* infection {#sec0030}
========================================

It is suggested that individual cats should be protected from the risk of becoming infected by *L. infantum* and of developing a clinical disease ([@bib0340]). Moreover, protection of feline populations is probably needed for a "One Health" strategy for the regional control of *L. infantum* infection. In fact, *Phlebotomus perniciosus* and *Lutzomyia longipalpis*, proven vectors of *L. infantum,* were found infected after feeding respectively on one single sick cat with FeL ([@bib0120]; [@bib0240]). This is an important information but infectivity to sand flies of infected healthy individuals, as demonstrated in dogs, could be epidemiologically more relevant as the percentage of antibody and/or PCR positive cats is often not negligible in endemic areas ([@bib0010]; [@bib0075]; [@bib0090], [@bib0095]; [@bib0160]; [@bib0215]; [@bib0225], [@bib0220]; [@bib0245]; [@bib0255]; [@bib0270]; [@bib0300]; [@bib0320], [@bib0315]; [@bib0435]; [@bib0490]; [@bib0520]). Prospective studies may confirm that cats play an epidemiological role as additional reservoir species of *L. infantum* as it was well established for dogs ([@bib0295]).

Pyrethroids are used in dogs for preventing the bites of sand flies but almost all are toxic to cats ([@bib0340]; [@bib0475]). However, the only pyrethroid formulation licensed for cats was able to reduce the incidence of *L. infantum* infection in kennelled dogs and in cats as well ([@bib0065], [@bib0055]).

According to current knowledge, testing of blood donors by antibody detection and blood PCR is the only advisable measure for preventing non-vectorial transmission to cats ([@bib0345])

7. Conclusion {#sec0035}
=============

Feline infection and the associated cat disease caused by *L. infantum* is increasingly reported in endemic areas and have many similarities with CanL. However, consolidated evidence-based knowledge about FeL is still not available and we cannot exclude that important differences between dogs and cats exist. In fact, we are still at an infancy stage of knowledge about transmission, immunopathogenesis, development, management and prevention of the feline disease and we make therapy empirically.

Published case reports of FeL are probably only the minimal part of all diagnosed cases and these latter can be only part of all occurring cases.

*Li: Leishmania infantum.*

CanL: Canine Leishmaniosis.

FeL: Feline Leishmaniosis.

[^1]: +++: present in ≥50% cases ++: present in \<50% cases +: present in \<25% cases NR: not reported.
